News

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?
HIV/Aids breakthrough not a 'cure', popular social media posts misrepresent the factsIN SHORT: While promising, a recent breakthrough in HIV research is not a "cure" or a "vaccine", as several posts ...
In a study of human immune cells infected with HIV, the virus that causes AIDS, scientists at Johns Hopkins Medicine say a ...
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...
Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that ...
World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...
Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.